Cardiac toxicity events in the PHARE trial, an adjuvant trastuzumab randomised phase III study
European Journal of Cancer2015Vol. 51(13), pp. 1660–1666
Citations Over TimeTop 10% of 2015 papers
Xavier Pivot, Thomas Suter, J.-M. Nabholtz, Jean‐Yves Pierga, Marc Espié, Alain Lortholary, David Khayat, Iris Pauporté, Gilles Romieu, Andrew Kramar, P. Fumoleau
Related Papers
- → Type 2 diabetes and heart failure: Characteristics and prognosis in preserved, mid-range and reduced ventricular function(2018)53 cited
- → Left Ventricular Function in Hospitalized Geriatric Patients(1982)77 cited
- → Mechanisms of Trastuzumab Resistance and Their Clinical Implications(2005)74 cited
- → Heart failure with preserved ejection fraction; the other half of the heart failure, how it stands in 2013(2014)
- → Chapter 9 Chronic heart failure with preserved ejection fraction(2008)